government while granting emergency use authorization (EUA) to any covid-19 vaccine in the country.Pfizer in India has sought more time from the government to make a presentation proposing emergency use authorisation (EUA) in the country, even as safety issues are already being debated in the UK, the first western country to approve a covid-19 vaccine.Also read: The pandemic push to the silver economyUK health authorities said on Wednesday that people with a "significant history of allergic reactions" should not be given the Pfizer/BioNTech coronavirus vaccine.
The precautionary advice came after two health care workers developed symptoms after receiving a shot.“As a precautionary measure, the MHRA (Medicines and Healthcare products.